doi: 10.1016/j.vaccine.2006.03.091.
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005
Affiliations
- PMID: 16838413
- DOI: 10.1016/j.vaccine.2006.03.091
Item in Clipboard
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005
Vaccine.
.
No abstract available
Similar articles
-
[Active immunization against serogroup B Neisseria meningitidis].Enferm Infecc Microbiol Clin. 2003 Nov;21(9):513-9. doi: 10.1016/s0213-005x(03)72998-x. Enferm Infecc Microbiol Clin. 2003. PMID: 14572386 Review. Spanish.
-
Neisseria meningitidis serogroup B: laboratory correlates of protection.FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):89-96. doi: 10.1111/j.1574-695X.2002.tb00608.x. FEMS Immunol Med Microbiol. 2002. PMID: 12381458 Review.
-
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.Infect Immun. 2006 Aug;74(8):4557-65. doi: 10.1128/IAI.00466-06. Infect Immun. 2006. PMID: 16861642 Free PMC article. Clinical Trial.
-
Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.Vaccine. 2007 Mar 30;25(14):2537-8. doi: 10.1016/j.vaccine.2005.12.059. Epub 2006 Jan 20. Vaccine. 2007. PMID: 16460845 No abstract available.
-
Meningococcal B vaccine development and evaluation of efficacy.Hum Vaccin. 2008 Mar-Apr;4(2):158-61. doi: 10.4161/hv.4.2.4871. Epub 2007 Aug 14. Hum Vaccin. 2008. PMID: 18388494
Cited by
-
Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.mSphere. 2020 Sep 16;5(5):e00376-20. doi: 10.1128/mSphere.00376-20. mSphere. 2020. PMID: 32938694 Free PMC article.
-
Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella.Hum Vaccin Immunother. 2020;16(1):197-205. doi: 10.1080/21645515.2019.1640427. Epub 2019 Aug 1. Hum Vaccin Immunother. 2020. PMID: 31287754 Free PMC article. Review.
-
Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine.NPJ Vaccines. 2020 Jan 29;5(1):8. doi: 10.1038/s41541-019-0154-0. eCollection 2020. NPJ Vaccines. 2020. PMID: 32025339 Free PMC article.
-
Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.Biologicals. 2019 Jan;57:9-20. doi: 10.1016/j.biologicals.2018.11.001. Epub 2018 Nov 18. Biologicals. 2019. PMID: 30458978 Free PMC article.
-
Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro.Clin Vaccine Immunol. 2009 Nov;16(11):1693-5. doi: 10.1128/CVI.00125-09. Epub 2009 Aug 26. Clin Vaccine Immunol. 2009. PMID: 19710292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
